中文名称 | 非昔硝唑 |
---|---|
英文名称 | Fexinidazole (HOE 239) |
CAS号 | 59729-37-2 |
分子式 | C12H13N3O3S |
分子量 | 279.31 |
外观 | Light yellow to yellow powder |
储存条件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Fexinidazole (Hoe239; Hoe-239) is a novel, potent and nitroimidazole-based antiparasitic agent that has been approved in 2021 by FDA as the first all-oral medication to treat African trypanosomiasis caused by Trypanosoma brucei gambiense. It acts well against diseases in both their initial and advanced stages. Its use in Chagas disease is also supported by some evidence.
© 2020-2024 凯立德生物医药技术(上海)有限公司 版权所有
沪ICP备15046197号-3
沪公网安备31011502007856号
Designed by Kuanersoft